Rani Therapeutics Holdings, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
RANI on Nasdaq
Location
2051 Ringwood Avenue, San Jose, California

Insiders trading volume in the past year

Rani Therapeutics Holdings, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Isidoro Quiroga 10%+ Owner $45.2 M Jul 30, 2021
South Cone Investments Limited Partnership 10%+ Owner $27.5 M +$10.6 M +62.4% Nov 24, 2023
Talat Imran Chief Executive Officer, Director $1.1 M +$86.5 K +8.54% Mar 21, 2024
Mir Hashim Chief Scientific Officer $620 K Mar 21, 2024
Svai Sanford Chief Financial Officer $587 K Mar 21, 2024
Eric Groen General Counsel $371 K Mar 21, 2024
Jean Luc Butel Director $115 K +$102 K +844% May 29, 2024
InCube Labs, L.L.C. 10%+ Owner $31.6 K Feb 3, 2022
Maulik Nanavaty Director $26.1 K +$990 +3.94% May 29, 2024
Cortes Isidoro Alfonso Quiroga 10%+ Owner $19.1 K -$10.6 M -99.8% Nov 24, 2023
Lyn Baranowski Director $13.8 K May 25, 2022
Kate McKinley Chief Business Officer Mar 21, 2024
Laureen Debuono Director May 29, 2024
Dennis A. Ausiello Director May 29, 2024
Mir A. Imran Director May 29, 2024
Andrew Farquharson Director May 29, 2024
Lisa Ann Rometty Director May 29, 2024

Recent Insider Transactions by Companies or Individuals for Rani Therapeutics Holdings, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership